| BIOXCEL THERAPEUTICS |
| USA |
| Gesundheit |
| US09075P2048 / A40YSR |
| BX20 (Frankfurt) / BTAI (NASDAQ) |
| FRA:BX20, ETR:BX20, BX20:GR, NASDAQ:BTAI |
| - |
| https://www.bioxceltherap.. |
|
BioXcel Therapeutics, Inc., together with its subs..
>Volltext.. |
| 34.31 Mio. EUR |
| 111.13 Mio. EUR |
| 0.75 Mio. EUR |
| -42.18 Mio. EUR |
| -44.05 Mio. EUR |
| -10.96 EUR |
| 94.19 Mio. EUR |
| 16.06 Mio. EUR |
| -48.21 Mio. EUR |
| 0.56 |
| -67.16% |
| 57.04% |
| - |
| - |
| - |
| - |
| BIOXCEL |
| 12.11.25 |
|
||||
|
||||
|
||||
|
||||
|